Company
United StatesPublic company, NASDAQ: DCTHDelcath Systems Inc. (NASDAQ: DCTH), New York, NY – FDA Inspections
Inspection records and compliance data for Delcath Systems Inc. in New York, New York. 1 FDA inspection on record, last inspected November 29, 2012. Publicly traded as NASDAQ: DCTH.
Company Profile
This profile covers Delcath Systems Inc. based in New York, New York, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 0
Inspected November 29, 2012.
Most cited issue areas
- Records of unused drug disposition1 inspection
- Transfer of obligations1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 29, 2012 | VAI | Human Drugs · Bioresearch Monitoring | 810210 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Delcath Systems Inc.
Stock ticker
DCTH
Exchange
NASDAQ
Share price
$14.52
Market cap
$503.8M
Price as of
November 6, 2026
FEI Number
3009797064
Address
810 7th Ave Suite 3505, New York, New York 10019, United States
Country
United States
ID: b492cbb6-ef6a-4c79-b55b-5325e38b9f10